A new study shows that a type of androgen-blocking drug, an aromatase inhibitor (marketed since 2005 to reduce the risk of breast cancer) is at least as effective against a common hormonal disorder as ...

Estrogen Receptor Expression and Efficacy of Docetaxel-Containing Adjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: Results From a Pooled Analysis Ovarian stimulation with ...

Ovarian stimulation with letrozole, an aromatase inhibitor, results in significantly fewer multiple gestations compared with gonadotropin among couples with unexplained infertility, according to a ...

A letrozole pill once a week restored fertility in obese, infertile men and led to their partners giving birth to two full-term, healthy babies, according to a new study from Canada. The results will ...

WASHINGTON—A drug used to increase a woman's chances of becoming pregnant may cause birth defects and miscarriages, according to a safety alert issued Monday by Canadian health regulators. The drug ...

WASHINGTON – The manufacturer of a breast cancer drug, letrozole, is warning fertility doctors that it has been associated with birth defects, a caution prompted by reports that the drug was being ...

For women with unexplained infertility, treatment with letrozole (Femara), an aromatase inhibitor, for ovarian stimulation yielded lower rates of multiple gestation, but also lower rates of clinical ...

The manufacturer of a breast cancer drug, letrozole, is warning fertility doctors that it has been associated with birth defects, a caution prompted by reports that the drug was being used to help a ...